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This study examines the time of appearance of myogenic determination factor (MDF) transcripts in developing chick
limbs and other embryonic tissues using reverse transcription±polymerase chain reaction (RT±PCR). In this assay, PCR
ampli®cation pro®les of cDNA samples from stage 15±26 limb buds are compared to those of E11 heart, a tissue operation-
ally de®ned as containing background levels of MDF transcripts which are thought to be nonfunctional. Myf 5 and MRF
4 transcripts are detected in stage 15 forelimbs, which is the earliest stage limb in which myogenic precursors have been
detected following their migration from the somite. In contrast, MyoD and myogenin transcripts do not appear until about
1.5 days later, closer to the time of cytological muscle differentiation. A survey of MyoD, myf 5, and MRF 4 transcripts
in other embryonic tissues reveals that MyoD transcripts are distributed in a highly skeletal muscle-speci®c pattern. In
contrast, myf 5 and MRF 4 mRNAs are detected at signi®cant levels in embryonic tissues that do not contain muscle or
muscle precursor cells such as stage 9±15 neural tubes and stage 9±12 lateral plates, while these transcripts are found at
very low levels in E11 heart and liver. The RT±PCR results are compared to those from in situ hybridization experiments
as well as from cell culture assays of the myogenic potential of early limb cells. q 1996 Academic Press, Inc.
INTRODUCTION half of the somite subsequent to dermomyotome formation
(see Ordahl, 1993, for review). In the chick embryo, cells
begin to leave the ventrolateral edge of the dermomyotomeMyogenic determination factors (MDFs) have been shown
at stage 14 and then migrate into the forelimb bud meso-to be important for skeletal muscle determination and dif-
derm which is derived from the lateral plate (Christ et al.,ferentiation. This study examines the developmental se-
1977). Muscle precursor cells can be detected in the fore-quence of MDF expression in the chick limb bud and at-
limb bud by stage 15 (Seed and Hauschka, 1984). In a similartempts to correlate this information with the overall prob-
manner, more caudal somitic cells at the hindlimb levellem of how the limb myogenic lineage becomes established.
begin to migrate at stage 15 and probably are present in theTransplantation and in vitro analyses of avian limb bud
hindlimb bud at stage 16 (Jacob et al., 1979).myogenesis have demonstrated that cells capable of muscle
Other cell culture assays and transplantation studies havedifferentiation are present well before cytologically detect-
examined when cells committed to the muscle lineage canable limb muscle differentiation (see Stockdale, 1992;
be found in the limb bud and, in addition, have identi®edHauschka, 1994, for reviews). Similarly, premyogenic cells
subpopulations of early limb myoblasts by their fusion prop-can be detected in mouse limb explant cultures more than
erties, growth requirements, and myosin heavy chain iso-a day before MDF transcripts can be found within the devel-
form expression (Bonner and Hauschka, 1974; White et al.,oping limb buds by in situ hybridization (Sassoon, 1989).
1975; Rutz and Hauschka, 1982; Miller and Stockdale, 1986;To achieve a more sensitive analysis of in vivo MDF gene
Seed and Hauschka, 1988; Van Swearingen and Lance-Jones,expression, we have developed a reverse transcription±poly-
1995). Most studies examining myogenic populations in themerase chain reaction (RT±PCR) assay to examine when
limb have entailed the growth and differentiation of muscleMDF transcripts can be detected in the developing chick
precursor cells in culture and have used relatively latelimb bud.
markers of muscle differentiation to identify cells in theThe limb and body wall muscles derive from the lateral
muscle lineage. More recently, it has been found by in situ
hybridization that Pax 3 expression marks the migratory
cells of the somite, but no MDF transcripts have been de-1 To whom correspondence should be addressed.
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tected in these cells (Bober et al., 1994; Williams and Or- In this study, we have used an RT±PCR analysis to inves-
tigate MDF expression in the developing chick limb buddahl, 1994).
MDFs (MyoD, myogenin, myf 5, and MRF 4) are transcrip- and other embryonic tissues. We chose to use RT±PCR
because its extreme sensitivity permits detection of verytion factors that are clearly involved in the process of mus-
cle differentiation (see Edmondson and Olson, 1993, for re- low mRNA levels in small numbers of cells. The population
of migrating myogenic precursors consists of only severalview). Expression of the MDF genes is hypothesized to play
an early mechanistic role in skeletal muscle development, thousand cells (Charles Ordahl and Bodo Christ, personal
communication), and initial expression of MDF genes insince in situ hybridization studies of mouse and chick em-
bryos indicate that MDF expression occurs at times and these cells is probably low. The MDF expression data were
then compared with earlier data from culture experimentsin locations in which the skeletal muscle lineage is being
established. A role for MDFs in determining the myoblast that have indicated when different populations of premyo-
genic cells are found in the limb. These comparisons pro-lineage is also supported by results from mice containing
double null mutations of myf 5 and MyoD, in which there vide insights as to possible relationships between cell deter-
mination state, myoblast diversity, and the expression ofwas a complete absence of muscle (Rudnicki et al., 1993).
Results from chimaeric mouse embryos containing cells MDF genes.
with the lacZ gene in the myf 5 locus have shown no b-
galactosidase staining in cells in the area between the so-
mite and the limb bud, supporting the hypothesis that the MATERIALS AND METHODS
premyogenic cells do not express MDFs until they reach
the permissive environment of the limb bud (Tajbakhsh and
Eggs. Chick embryos were obtained from fertilized White Leg-Buckingham, 1994).
horn eggs (H and N International, Redmond, WA) which had beenMDFs are expressed sequentially during development,
incubated in a forced draft incubator at 37±387C, 100% humidity.
suggesting different roles for each factor during muscle de- Developmental stages were ascertained according to the criteria of
velopment in the embryo. In situ hybridization studies by Hamburger and Hamilton (1951).
Pownall and Emerson (1992) examined the expression of Embryo dissection and RNA extraction. Embryos were dis-
qmf 1, 2, and 3 (quail homologues of MyoD, myogenin, and sected in cold, diethyl pyrocarbonate (DEPC)-treated, phosphate-
buffered saline. Forelimbs, hindlimbs, hearts, livers, and other em-myf 5) in stages 12 and 13 quail embryos. By analyzing
bryonic tissues were removed from single or multiple embryos us-expression with respect to the rostral±caudal position of
ing electrolytically sharpened tungsten needles (Fig. 1). Distal andthe somites, they determined that MyoD is expressed ®rst;
proximal fore- and hindlimb samples were obtained from stage 25/MyoD transcripts were detected in the younger, more cau-
26 embryos (Fig. 1D). The distalmost quarter of the fore- or hind-dal somites, while myf 5 transcripts colocalized with MyoD
limb was dissected away from the remaining proximal portion oftranscripts only in the older, more rostral somites of stage
the limb using tungsten needles. Lateral plate tissue and neural
12. Myogenin transcripts were not detected in somites until tubes were obtained from embryos after trypsin treatment of the
stage 13. In avian limb buds, MyoD transcripts were ®rst embryos (Fig. 1A). These embryos were removed from extraembry-
detected at stage 24 (Charles de la Brousse and Emerson, onic membranes in 47C Ham's F10C (F10 supplemented with 0.8
Jr., 1990; Williams and Ordahl, 1994). The sequence of MDF mM Ca2/ and 0.05 mg/ml gentamicin, Sigma) and were pinned
with tungsten wires to a dissection dish containing Sylgard 184gene expression in the avian limb bud has not been exam-
elastomer (Dow Corning) blackened with activated charcoal. Afterined extensively by in situ hybridization, so it is unknown
removal of the F10C, 2 mg/ml trypsin (Worthington) at room tem-whether the different factors are expressed in a sequence
perature was applied to cover the embryos (100±200 ml). The ecto-similar to that in the somite. In situ hybridization and RT±
derm of the embryo was removed with tungsten needles, and thePCR analyses of developing mouse somites and limb buds
lateral plate and neural tube were then separated from the somites.have revealed a different sequence of MDF expression from
For all samples, the tissue was dissolved in 500±1000 ml of 4 M
chick embryos. Myf 5 transcripts were detected by in situ guanidine thiocyanate/8% b-mercaptoethanol solution. Total RNA
hybridization in the earliest mouse somites followed by was isolated essentially as described in Chomczynski and Sacchi
myogenin, MRF 4, and ®nally, MyoD. In the mouse limb (1987), except that the ®rst precipitation was performed at 0207C
bud, myf 5 was again the ®rst MDF transcript detected, with an equal volume of isopropanol for a minimum of 16 hr,
followed by a 30-min 45,000-rpm spin at 47C in a Beckman tabletopand MyoD and myogenin were coexpressed in later stages
ultracentrifuge (TL100). The RNA pellets were then processed as(Sassoon et al., 1989; Ott et al., 1991). MRF 4 mRNA was
in Chomczynski and Sacchi (1987), and each RNA sample wasdetected 2 days later than MyoD and myogenin mRNA in
quanti®ed spectrophotometrically at 260 nm.the mouse limb (Bober et al., 1991; Hinterberger et al.,
RT±PCR. One microgram of total RNA was used for RT±PCR1991). However, RT±PCR with mouse MRF 4 primers de-
for all primer pairs except for the cytoplasmic b-actin primers, fortected transcripts in limb stages containing myf 5 but not
which 100 ng of total RNA was used. The RNA was denatured
MyoD and myogenin transcripts (Hannon et al., 1992). The brie¯y with 1 unit of inhibit-ACE (5prime3prime, Inc.) and 0.2 mg
RT±PCR data with the other mouse MDF primers in the oligo (dT)(15) primer (Promega) at 657C for 5 min. Then 11 PCR
somite and the limb were similar to in situ hybridization buffer (Promega), 1.5 mM MgCl2, 1 mM each dNTP, and 200 units
data, although the times of activation were detected slightly MMLV Reverse Transcriptase (Gibco-BRL Life Technologies, Inc.)
were added to a ®nal reaction volume of 20 ml. Reverse transcrip-earlier with RT±PCR.
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TABLE 1
PCR Primers
Primer Primer sequence cDNA regions
MyoD (CMD1)a
Pair ``a'' Forward: TACCCAGTGCTGGAGCACTA Identical to nt 641±660
Reverse: GTCTTGGAGCTTGGCTGAAC Complementary to nt 1092±1111 in 3*
untranslated region
Pair ``b'' Forward: GGACATGCACTTCTTCGAGG Identical to nt 250±269
Reverse: TCTCCTGCGAGAGCTACAGG Complementary to nt 732±751
Myogeninb Forward: ACGAGCCTCAACCAGCAGGA Identical to nt 432±451
Reverse: TCTGCCTGGTCATCGCTCAG Complementary to nt 591±610
Myf 5c
Pair ``a'' Forward: AGGGAACAGGTGGAGAACTA Identical to nt 552±573 in exon 1
Reverse: TCATAGCGCCTGGTAGGTCC Complementary to nt 1302±1321 in exon 3
Pair ``b'' Forward: CCCTGAGGAAGAGGAACACG Identical to nt 281±300 in exon 1
Reverse: GATGCTGGAGAGGCAGTCCA Complementary to nt 1164±1183 in exon 3
MRF 4d Forward: AGGCTGGATCAGCAGGACAA Identical to nt 459±478
Reverse: CACATTTCTCCACCGCCTCT Complementary to nt 782±741
Cytoplasmic b-actine Forward: AATGAGAGGTTCAGGTGCCC Identical to nt 3140±3159 in exon 4
Reverse: ATCACAGGGGTGTGGGTGTT Complementary to nt 4190±4209 in 3*
untranslated region
a Lin et al. (1989)
b Fujisawa-Sehara et al. (1990)
c Saitoh et al. (1993)
d Fujisawa-Sehara et al. (1992)
e Kost et al. (1983)
tion reactions were incubated for 10 min at room temperature, 60 All PCR primers were synthesized by the University of Washing-
ton Howard Hughes Chemical Synthesis Facility. Primers for genesmin at 427C, and 5 min at 957C. The whole reverse transcription
reaction was diluted to 100 ml ®nal volume with 11 PCR buffer, whose genomic structure is known were designed such that the
ampli®ed sequence spanned introns. As the exon±intron structures1±1.5 mM MgCl2 (concentration dependent on primer pair used),
20 pmol each of forward and reverse primer, and 2 units of Taq of chick MyoD, myogenin, and MRF 4 have not been published,
primers were designed to areas of the cDNA that would span in-polymerase (Promega). The MRF 4 primers and the ``a'' set of myf
5 primers were used in PCR reactions that contained a 1.0 mM trons in the homologous mouse sequence. Sequences of the primers
are shown in Table 1.MgCl2 ®nal concentration. All the remaining sets of primers used
a 1.5 mM MgCl2 concentration. Samples were overlaid with paraf- Determination of PCR primer pair sensitivity. DNA fragments
containing sequences of the MDFs were isolated from cDNA plas-®n oil (80 ml) and ampli®ed in a Thermocycler (Eppendorf). The
cycling parameters were as follows: the initial cycle consisted of a mids and used in PCR assays to quantify the range of target mole-
cules that each primer pair can amplify in a given number of cycles.957C denaturation for 5 min, 1 min at a 557C annealing tempera-
ture, and 1 min at a 747C extension temperature. The remaining For the MyoD primers, the DNA used in the PCR was the 1.5-kb
EcoRI insert of CMD1 in Bluescript KS (Lin et al., 1989). An 800-cycles were for 1 min each at 957, 557, and 747C, with the ®nal
cycle having a 10-min extension at 747C. The total number of cy- bp EcoRI insert from a chick myogenin clone (Saitoh et al., 1993)
was used to test the myogenin primers. The target DNAs for myf 5cles varied from 15 to 40 depending on the primer pair used. Fifteen-
microliter samples of each reaction were removed every 2±5 cycles and MRF 4 were derived from EcoRI/BamHI digests of pBS plasmids
containing RT-PCR products cloned into the SmaI site of the plas-in the last 10±15 cycles. PCR products were analyzed by electro-
phoresis of 12.5 ml of each sample on a 3% NuSieve (FMC Corp.)/ mid. Each target DNA was quanti®ed on a ¯uorimeter with
Hoescht stain and diluted in water to give the appropriate number1% agarose gel, followed by ethidium bromide staining. Further
veri®cation of PCR product identity was determined by size, se- of copies of DNA. These dilutions were used in 100-ml PCR reac-
tions under conditions identical to those described above for thequencing of PCR clones, Southern blot hybridization, or diagnostic
restriction digests. The restriction enzymes used to verify PCR RT±PCR, and the results of the PCR assay were analyzed identi-
cally to the RT±PCR studies. The amount of DNA used in eachproduct identity yielded characteristic restriction fragments. PvuII
was used to digest PCR products from reactions containing myf 5, PCR reaction (i.e., the number of target molecules) was compared
to the cycle number at which the product was ®rst visible. ThisMyoD, or myogenin primers, and NcoI was used to digest MRF 4
PCR products. indicated the approximate number of target molecules that could
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TABLE 2 suf®cient to detect background levels of these transcripts
Sensitivity of PCR Primers in nonskeletal muscle tissues (see subsequent sections).
Range of the number of
Myogenic determination No. of target molecules that Myogenic Determination Factor Transcript
factor PCR primer PCR cycles can be detecteda Detection in Developing Embryonic Chick
Limb Buds
Myf 5d 25 1100b, 1380c
40 1±15 RT±PCR analysis was used to detect MDF mRNAs in
Myogenin 25 5500, 11,000 chick embryo fore- and hindlimbs (Figs. 1B and 1C) from
MyoDd 25 11,000, 30,000 single or multiple embryos of various stages using the prim-
MRF 4 25 11,000, 30,000 ers in Table 1. A pro®le of the PCR ampli®cation for each
cDNA was obtained by removing a sample every 2±5 cyclesa This range gives an approximation of how many target mole-
during the last 10±15 PCR cycles. The total number of cy-cules are required to give visible product on an ethidium bromide
cles was dependent on the primer pair used since differentstained agarose gel given a particular number of PCR cycles.
primer pairs detect background transcripts after differentb The smaller number in the range represents the greatest number
of target molecules tested that failed to amplify visible product. cycle numbers. In the analysis of each RT±PCR experiment,
c The greater number in the range represents the smallest number the minimum number of cycles that were required to visu-
of target molecules tested that produced visible product following alize the correct PCR product on a gel from a nonskeletal
ampli®cation. muscle tissue (E11 heart) was determined. This minimum
d The ``a'' set of myf 5 and MyoD primers were used in these number was then operationally de®ned as the cycle number
studies. that detects background transcript levels from the MDF
gene being examined, since MDF mRNAs are not detected
in heart by in situ hybridization analyses (Buckingham et
al., 1992) or by Northern analysis (e.g., MyoD (Davis et al.,
be detected at a given PCR cycle number for each of the different
1987)). E11 liver also exhibits similar background levels ofsets of primers.
MDF transcripts (see below, Table 4, and Figs. 4 and 5). If
the limb sample run in parallel with the E11 heart sample
showed a similar PCR ampli®cation pro®le to heart, or re-RESULTS
quired a greater number of cycles before the speci®c PCR
product was detected, then that sample was interpreted asSensitivity of Myogenic Determination Factor PCR containing background levels of the target mRNA, as opera-Primers tionally de®ned by this RT±PCR assay system. However,
if the PCR product was detectable at a lower cycle numberA pair of PCR primers for each of the four MDF cDNAs
was used in PCR assays with known quantities of plasmid than heart, then the experimental sample was considered
to have signi®cant levels of the target mRNA.derived target DNA to determine the approximate numbers
of target molecules the PCR primers were capable of ampli- An example of one MDF analysis is shown in Fig. 2 in
which the ``a'' set of myf 5 primers was used to amplifyfying (Table 2). For each primer pair the smaller number in
the range represents the greatest number of target molecules cDNA generated from stage 15±22 forelimb buds and E11
heart. In this particular experiment, no background myf 5tested that failed to produce visible product. The greater
number in the range of target molecules represents the transcripts were detectable in E11 heart even after 40 PCR
cycles (Fig. 2A), suggesting that few if any myf 5 transcriptssmallest target number tested that produced visible product
following ampli®cation. were present in E11 heart. The 360-bp myf 5 PCR product
was observed in the stage 15±22 forelimb samples after asThe four sets of MDF PCR primers exhibited different
sensitivities. The myf 5 primers appear to be the most sensi- few as 27±29 PCR cycles, indicating signi®cant levels of
myf 5 transcripts in all of these samples. The ``b'' set of myftive since 25 PCR cycles were suf®cient to amplify approxi-
mately 1400 target sequences. In fact, the myf 5 primers 5 primers was used in other experiments to verify RT±PCR
results from the ``a'' set; similar results were observed. Thecan amplify a single target sequence with 40 PCR cycles.
The remaining MDF primers required greater than 5500 myf 5 PCR products ampli®ed are of the predicted size and
are cut to the appropriate 342-bp fragment in diagnostictarget molecules in order to produce visible product after
25 cycles. Myogenin PCR primers required 11,000 targets PvuII restriction digests. The identity of the myf 5 PCR
product obtained with these primers has also been con-with 25 PCR cycles, while MyoD and MRF 4 primers re-
quired about twice this number of target sequences, indicat- ®rmed by sequencing (data not shown). Cytoplasmic b-actin
primers were also used in parallel reactions in the sameing that the myogenin primers are more sensitive than the
MyoD and MRF 4 primers. Although the myogenin, MyoD, experiment to verify the integrity and quanti®cation of the
RNA for each sample (Fig. 2B). All the cDNA samples exhib-and MRF 4 primers are less sensitive than the myf 5 primers,
RT±PCR reactions with these primers did not require fur- ited ef®cient ampli®cation of the 409-bp cytoplasmic b-
actin PCR product after 20 cycles.ther optimization, since the sensitivity of the reactions was
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FIG. 1. Embryonic tissues dissected and used for RT±PCR assays. All embryos are oriented such that the rostral end of the embryo is
at the top of the page. (A) Stage 12 embryo after treatment with trypsin and partial removal of the overlying ectoderm (E) is shown. Arrows
(with points) indicate the edge of the ectoderm. In the dissection, lateral plate tissue (LP) was removed after removal of somites, segmental
plate mesoderm, and neural tube (arrowheads). The dotted lines demarcate the approximate cuts made for the dissection for lateral plate
tissue which includes not only mesoderm but the underlying endoderm. (B) Stage 15 embryo showing the area of forelimbs dissected
(dotted line). H, heart. (C) Caudal half of a stage 23 embryo showing the approximate cuts made for the dissection of the hindlimb (HL).
(D) Caudal half of a stage 25 embryo showing the approximate cuts (dotted lines) made during dissection of the distal quarter (D) and
remaining proximal portion (P) of the hindlimb (outlined by dotted line). Bars, approximately 1 mm.
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FIG. 2. Detection of myf 5 transcripts by RT±PCR in stage 15±22 chick forelimbs. The ``a'' set of myf 5 PCR primers (A) or cytoplasmic
b-actin PCR primers (B) were used to amplify cDNA made from E11 heart and stage 15±22 forelimb total RNA. (A) Myf 5 transcripts
were not detected in heart even after 40 PCR cycles. In stage 15±22 forelimb samples, the 360-bp PCR product was detectable by ethidium
bromide staining with 40 or fewer cycles. Veri®cation of the 360-bp PCR product as the targeted portion of cDNA was con®rmed by a
PvuII digest of the 40-cycle samples to yield the predicted 342-bp product. The stage 22 forelimb control reaction that contained no reverse
transcriptase (-RTase) failed to amplify product after 40 cycles. (B) The 409-bp cytoplasmic b-actin PCR product was detected from 100
ng of total RNA for all the samples after 20 cycles, thus verifying the integrity of RNA samples that exhibited no PCR product with myf
5 primers. Only nonspeci®c products were seen in the cytoplasmic b-actin minus reverse transcriptase control reaction after 30 cycles
using liver (or any other sample).
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FIG. 3. Detection of MRF 4, MyoD, and myogenin transcripts by RT±PCR in various stages of fore- or hindlimbs. (A) MRF 4 and
cytoplasmic b-actin PCR primers were used to amplify cDNA made from E11 heart, stage 15 forelimbs, and stage 16 hindlimbs. Background
levels of the 283-bp product were detected in the heart sample after 33 cycles. The stage 15 forelimb and stage 16 hindlimb samples
produced visible PCR product after 29 cycles. (B) The ``a'' set of MyoD and the cytoplasmic b-actin PCR primers were used to amplify
cDNA made from E11 heart and stages 23 and 24 hindlimbs. The E11 heart and stage 23 hindlimb samples exhibited the 470-bp MyoD
PCR product after 25 cycles, and 22 cycles of PCR were required to produce visible levels of MyoD product from stage 24 hindlimbs.
Although MyoD PCR products appear in E11 heart and stage 23 hindlimb at the same cycle number, the intensity of the two bands may
re¯ect a slightly higher MyoD mRNA level in stage 23 hindlimb. Some stage 23 hindlimb samples clearly contain MyoD mRNA levels
above background, while others clearly contain background levels (Table 3). These differences between samples may re¯ect the transitional
nature of MyoD activation. (C) Myogenin and cytoplasmic b-actin PCR primers were used to amplify cDNA from E11 heart and stages
24 and 25 forelimbs. The 205-bp myogenin PCR product was seen after 30 cycles in E11 heart and stage 24 forelimb samples, and the
stage 25 forelimb sample exhibited myogenin PCR product after 25 cycles. The E11 heart reaction also contained a PCR product of higher
molecular weight which is most likely due to nonspeci®c ampli®cation with the myogenin primers. The identities of the MDF PCR
products were veri®ed by diagnostic restriction digests, and no speci®c products were detected in reactions without reverse transcriptase
(data not shown). All cDNA samples exhibited ef®cient ampli®cation of the 409-bp cytoplasmic b-actin product.
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TABLE 3
Myogenic Determination Factor Transcript Detection in Limb Buds
Forelimb Hindlimb
Myogenic No. of embryos No. of embryos
determination No. of embryos showing No. of embryos showing
factor Embryo stage examineda expressionb examineda expressionb
Myf 5 r 15c 5 5 d d
r 16e 4 4 6 6
17 4 3 4 4
18 5 4 5 4
19 3 3 3 3
20 2 2 2 2
21 2 2 2 2
22 2 2 2 2
MRF 4 r 15c 3 3 d d
r 16e 4 3 4 4
17 4 3 4 3
18 3 3 3 3
19 3 2 4 3
20 5 2 6 4
21 5 4 5 3
22 5 4 4 3
23 4 4 3 3
24 3 3 4 3
25 4 4 3 3
26 3 3 3 3
MyoD 22 3 0 3 0
r 23f 4 2 4 2
r 24f 3 2 3 3
25 3 3 3 3
Myogenin 21 2 0 N.D.g N.D.
22 2 0 3 0
r 23e 4 1 7 4
24 6 2 6 4
r 25c 4 4 4 4
26 2 2 2 2
a Greater numbers of embryos were examined for stages near the time of onset of expression.
b A gene was considered to show signi®cant expression if the levels of expression in the limb bud were higher than levels found in E11
heart, a tissue considered to be negative for MDFs.
c Earliest embryo stage in which signi®cant levels of MDF expression were consistently detected in the forelimb.
d Hindlimb buds are too small to dissect cleanly at stage 15.
e Earliest embryo stage in which signi®cant levels of MDF expression were consistently detected in the hindlimb.
f Signi®cant levels of MyoD expression were consistently detected in both stage 23/24 forelimbs and hindlimbs.
g N.D., not determined.
The other three MDF PCR primers were also used to along with those of myf 5, were the earliest MDF mRNAs
to be detected in the limb buds examined in this study. Forexamine the stages at which transcripts from these genes
could ®rst be detected above background levels. Examples technical reasons (i.e., minute limb bud size and limb bud
proximity to somites), it was not possible to remove fore-of results from these experiments are shown in Fig. 3, and
the composite results from analyses for all four MDF tran- and hindlimb buds prior to stages 15 and 16. MyoD tran-
scripts were ®rst found several stages later than myf 5 andscripts are presented in Table 3. The MRF 4 primers pro-
duced a 283-bp PCR product that was found in stage 15 MRF 4 transcripts in stage 23/24 fore- and hindlimbs. For
example, in Fig. 3B, a stage 23 hindlimb sample exhibitedforelimbs and stage 16 hindlimbs after 29 PCR cycles, 4
cycles earlier than in E11 heart (Fig. 3A). MRF 4 transcripts, a similar pro®le of MyoD RT±PCR ampli®cation to that
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observed in E11 heart. The 470-bp product was ®rst seen in MyoD, myf 5, and MRF 4 mRNAs was carried out in sam-
ples from E11 heart, E11 liver, neural tubes from stage 9±both samples after 25 cycles, thus implying that the stage 23
hindlimb contains background levels of MyoD transcript, 15 embryos, lateral plate tissue (without ectoderm) from
stage 9±12 embryos (Fig. 1A), and the distal and proximaldespite the greater intensity of the stage 23 hindlimb MyoD
PCR product than that of E11 heart. Indeed, the MyoD data regions of stage 25/26 limb buds (Fig. 1D, Table 4). Lateral
plate tissue was included because it does not contain cellsfrom Table 3 suggests that stage 23 is the transitional period
for MyoD activation since half the limb samples exhibited which fate map to the myogenic lineage, but it does give
rise to the other mesodermal lineages of both the proximalabove background levels of MyoD transcripts in both the
fore- and hindlimbs. In contrast, almost all of the stage 24 and distal regions of the limb bud (Christ et al., 1977). The
distalmost 1/4 of the stage 25/26 limb bud was of interest,limb buds contained MyoD transcript levels that are greater
than background (Table 3); for example, the stage 24 hind- because previous clonal assays had indicated that this limb
region is devoid of myogenic precursor cells (Rutz et al.,limb sample depicted in Fig. 3B contained MyoD mRNA
levels that were detected at least 3 cycles earlier than the 1982). The identities of the PCR products ampli®ed from
all tissues were veri®ed by restriction enzyme digests.background levels detected in E11 heart. A second set of
MyoD primers con®rmed that the temporal difference in To make the distinction between positively regulated and
leaky transcription rigorous, signi®cant levels of MyoD,MyoD transcript levels between limb stages was not due
to gross differences in primer sensitivity, i.e., both sets of myf 5, or MRF 4 PCR products were de®ned as being greater
than four times higher ( 2 PCR cycles different) than thoseprimers gave similar results with respect to the stages when
the MyoD transcripts were ®rst detected above background detected in parallel E11 heart samples. The tissue distribu-
tion of MyoD transcripts showed strong skeletal muscle(data not shown).
With myogenin-speci®c PCR primers, the 205-bp myo- speci®city. An example of one experiment that contrasts
MyoD and myf 5 expression in a variety of embryonic tis-genin PCR product was clearly visible in the E11 heart sam-
ple after 30 PCR cycles (Fig. 3C). The stage 24 forelimb sues is shown in Figs. 4 and 5. With the exception of the
proximal stage 25/26 limb bud in which overt skeletal mus-exhibited a PCR cycling pro®le similar to that of E11 heart,
thus indicating that it contained myogenin transcript levels cle differentiation is occurring, only background levels of
MyoD mRNA were seen in all the other embryonic tissuesat background levels. In contrast, the myogenin PCR prod-
uct was seen in the stage 25 forelimb after only 25 cycles. tested (Fig. 4 and Table 4). In contrast, lateral plate, neural
tube, and both distal and proximal portions of stage 25/26This was signi®cantly above background and suggests that
myogenin gene expression has been activated in myogenic limb buds contained signi®cant levels of myf 5 transcripts
when compared with heart (Fig. 5). E11 liver, like E11 heart,cells of stage 25 forelimbs. A third of the stage 24 forelimb
bud samples examined showed signi®cant levels of myo- contained background levels of myf 5 transcripts.
Results with MRF 4 primers are summarized in Table 4genin expression (Table 3). However, a majority of the stage
23 and 24 hindlimb buds exhibited myogenin mRNA levels along with data from other experiments with MyoD and
myf 5 primers in other embryonic tissues. The myf 5 andabove background. The slightly earlier detection of myo-
genin in hindlimb vs forelimb differed from the more equiv- MRF 4 genes exhibited much less developmental and mus-
cle-speci®c expression. Myf 5 products were not detectablealent timing of initial expression of the other three MDFs
in the fore- and hindlimbs. Myogenin expression also ap- after 40 PCR cycles in E11 heart and liver, whereas rela-
tively abundant levels of myf 5 transcripts were detectedpeared to rise above background slightly later than MyoD
expression, and initiation of its expression more closely co- in neural tube and lateral plate from earlier embryonic
stages (Fig. 5). Similarly, MRF 4 transcripts were detectedincided with the onset of limb bud muscle differentiation.
at signi®cant levels in 4 of 7 neural tube samples as well
as in 6 of 6 lateral plate samples. Signi®cant myf 5 and MRF
Detection of myf 5, MRF 4, and MyoD Transcripts 4 expression were also detected in the proximal portion
in Skeletal and Nonskeletal Muscle Tissues of stage 25/26 limb buds. This was expected since muscle
differentiation in proximal limb regions is apparent at thisIn the analysis of limb bud MDF transcripts described in
the previous section, we interpreted the detection of low stage. However, signi®cant myf 5 expression was also de-
tected in 9 of 11 distal 1/4 limb bud regions where myogeniclevels of MDF transcripts in E11 heart as being due to
``leaky'' transcription. For example, MyoD PCR products cells are not thought to reside. MRF 4 expression in distal
limb regions was more variable than that of myf 5, withwere typically visible in heart samples after 25 cycles (Fig.
3B), whereas myf 5 mRNA was usually undetected in heart only 7 of 11 stage 25/26 limb bud tips exhibiting signi®cant
MRF 4 transcript levels.after 40 PCR cycles (Fig. 2A). Since the myf 5 primers can
theoretically produce visible product from a single target
molecule after 40 cycles (Table 2), these data suggest a lower
level of leaky expression from the myf 5 gene relative to DISCUSSION
that of MRF 4, MyoD, and myogenin.
To assess MDF muscle speci®city vs background MDF This study characterized the temporal appearance of MDF
transcripts in developing chick fore- and hindlimbs usinglevels in other embryonic tissues, RT±PCR analysis of
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TABLE 4
Detection of MyoD, myf 5, and MRF 4 Transcripts in Skeletal and Nonskeletal Muscle Tissue
Samples at Samples 3±4 Samples ⁄5
No. of samples background cycles above cycles above
Tissue examined levelsa heart levels heart levels
MyoD
E 11 liver 6 6 0 0
Stage 9±15 neural tube 8 7 1 0
Stage 9±12 lateral plate 6 6 0 0
Stage 25/26 distal 1/4 forelimb buds 5 5 0 0
Stage 25/26 distal 1/4 hindlimb buds 6 6 0 0
Stage 25/26 proximal 3/4 forelimb buds 5 0 1 4
Stage 25/26 proximal 3/4 hindlimb buds 6 0 1 5
Myf 5
E 11 liver 7 6 0 1
Stage 9±15 neural tube 8 1 0 7
Stage 9±12 lateral plate 6 0 0 6
Stage 25/26 distal 1/4 forelimb buds 5 0 0 5
Stage 25/26 distal 1/4 hindlimb buds 6 2 0 4
Stage 25/26 proximal 3/4 forelimb buds 5 0 0 5
Stage 25/26 proximal 3/4 hindlimb buds 6 0 0 6
MRF 4
E 11 liver 5 5 0 0
Stage 9±15 neural tube 7 3 4 0
Stage 9±12 lateral plate 5 0 0 5
Stage 25/26 distal 1/4 forelimb buds 5 0 3 2
Stage 25/26 distal 1/4 hindlimb buds 6 4 1 1
Stage 25/26 proximal 3/4 forelimb buds 5 0 0 5
Stage 25/26 proximal 3/4 hindlimb buds 5 0 0 5
a Background levels of MDF transcripts in this analysis are de®ned as levels in which the speci®c PCR products are detected 2 or fewer
cycles earlier than in E11 heart or later than E11 heart, a tissue considered negative for MDFs.
RT±PCR. Myf 5 and MRF 4 mRNAs were detected in the than those of the hindlimb, and precursors to the forelimb
muscles leave the somite a stage earlier than those of hind-earliest forelimbs (stage 15) and hindlimbs (stage 16) that
were feasible to examine. Detection of myf 5 and MRF 4 limb muscles. Because myf 5 and MRF 4 transcripts were
detected in the earliest limbs that can be dissected, it cannottranscripts at stage 15 correlates with prior studies in which
cells capable of muscle colony formation were detected in be determined whether these mRNAs appear in the fore-
limb before the hindlimb. However, by stage 23, MyoD tran-stage 15/ forelimbs (Seed and Hauschka, 1984). The initial
appearance of MyoD and myogenin mRNA occurs later scripts can be detected above background levels in both
forelimb and hindlimb. The simultaneous expression ofthan myf 5 and MRF 4, but precedes the initial expression
of muscle structural genes at stage 26 (Charles de la Brousse MyoD suggests that forelimb and hindlimb muscle develop-
ment are equivalent by stage 23. However, the slight tempo-and Emerson, Jr., 1990). It is important to emphasize that
the myf 5 and MRF 4 transcripts detected in limbs are not ral difference between fore- and hindlimb with respect to
the earliest detection of myogenin mRNA may indicate thatattributable to somite contamination. This conclusion is
based on the fact that MyoD and myogenin mRNAs were terminal differentiation begins in hindlimb muscle about a
stage prior to its initiation in the forelimb (Table 3).not detected at levels above background in stage 15 and
16 limbs, and yet the potentially contaminating limb level The order of MDF expression in the chick limb detected
by our studies differs from the sequence reported in mousesomites already contain differentiated axial muscle in
which these mRNAs are readily detected (Lin-Jones and and avian somites and in mouse limbs as detected by in
situ hybridization (Pownall and Emerson, 1992; see LyonsHauschka, unpublished observations).
Comparison of the appearance of MDF transcripts in fore- and Buckingham, 1992, for review of mouse data), and in
mouse embryos as detected by RT±PCR (Hannon et al.,limb vs hindlimb reveals no temporal difference as to when
myf 5, MRF 4, and MyoD are ®rst detected. Due to the 1992). Our results show that myf 5 and MRF 4 are the ®rst
MDF transcripts in developing chick limbs and that theserostral±caudal gradient of somite development, somites
from which the forelimb muscles are derived form earlier are present as early as stages 15 and 16 in the fore- and
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the order of MDF transcript appearance is relatively similar
between the two species. Myf 5 is the earliest MDF gene
to be activated in both mouse somites and limbs (Ott et al.,
1991), while MyoD and myogenin are coexpressed later in
the mouse limb (Sassoon et al., 1989). One major discrep-
ancy in the temporal expression of MDFs in mouse and
chick limbs is the detection of MRF 4 transcripts. Chick
MRF 4 mRNA, like myf 5, was found in the earliest limb
stages, eight stages before MyoD and myogenin transcripts
(Table 3). In mouse limbs, MRF 4 mRNA was not detected
by in situ hybridization until 2±3 days after the other MDF
mRNAs (Bober et al., 1991; Hinterberger et al., 1991). How-
ever, an RT±PCR analysis of mouse limbs showed MRF 4
transcripts present at the same early stages in which myf 5
transcripts were detected (Hannon et al., 1992). This result
is consistent with our ®ndings in the chick limb as well as
with the temporal pattern in mouse somites.
FIG. 4. Detection of MyoD transcripts by RT±PCR in embryonic
muscle and nonmuscle tissues. The ``a'' set of MyoD PCR primers
was used to amplify cDNA made from E11 heart and liver, lateral
plate (without ectoderm) from stage 9±12 embryos, neural tube
from stage 9±15 embryos, and the distalmost quarter and remaining
proximal three-quarters of stage 25/26 hindlimbs. Background lev-
els of MyoD transcripts, de®ned by E11 heart levels, were detected
in E11 liver, lateral plate tissue, neural tube, and the distal portion
of stage 25/26 hindlimb. These samples produced visible 470-bp
MyoD PCR product after 22 or more cycles. Only the proximal
portion of the stage 25/26 hindlimb exhibited the 470-bp MyoD
product after 20 cycles. Veri®cation of the PCR product as the
targeted portion of MyoD cDNA was con®rmed by restriction di-
gest with PvuII. No ampli®cation was seen in the stage 25/26 proxi-
mal hindlimb sample after 30 cycles in the absence of reverse tran-
scriptase (-RTase). All cDNA samples exhibited ef®cient ampli®-
cation of the 409-bp cytoplasmic b-actin product and veri®ed the
integrity of the RNA samples (data not shown).
FIG. 5. Detection of myf 5 transcripts by RT±PCR in embryonic
muscle and nonmuscle tissues. The ``a'' set of myf 5 PCR primers
hindlimbs. Extensive in situ hybridization analysis of MDF was used to amplify cDNA made from E11 heart and liver, lateral
transcripts in early chick limbs has yet to be reported, but plate (without ectoderm) from stage 9±12 embryos, neural tube
the detection of MyoD mRNA in stage 24 limbs (Williams from stage 9±15 embryos, and the distalmost quarter and remaining
proximal three-quarters of stage 25/26 hindlimbs. No backgroundand Ordahl, 1994) is consistent with our RT±PCR data (Ta-
level of myf 5 was detected in E11 heart or liver even after 40 PCRble 3). During avian somitogenesis, MyoD was the earliest
cycles. The 360-bp myf 5 PCR product was visibly ampli®ed withMDF gene expressed as detected by in situ hybridization of
40 or fewer cycles in samples from neural tube, lateral plate, andstages 12 and 13 quail embryos (Pownall and Emerson,
distal and proximal portions of stage 25/26 hindlimbs. Veri®cation1992). In that study, myf 5 and myogenin transcripts were
of the PCR product as the targeted portion of the myf 5 cDNA wasdetected in somites later than MyoD transcripts, whereas in
con®rmed by restriction digest with PvuII. No ampli®cation was
our RT±PCR studies of chick limbs, MyoD and myogenin seen with myf 5 primers in the absence of reverse transcriptase
mRNAs were detected 8 stages or approximately 30 hr later (-RTase) after 40 cycles. The cDNA samples used for ampli®cation
than myf 5 and MRF 4 mRNA. of the myf 5 PCR products shown in this ®gure were the same
Comparison of chick limb RT±PCR data with mouse used for ampli®cation of the MyoD PCR products (shown in Fig.
4) in the same experiment.limb in situ hybridization and RT±PCR data indicates that
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Myf 5 gene expression in mouse limb development has tivity assays after 40 cycles (Table 2) (see below for further
interpretation of low level MDF transcripts).also been studied in chimaeric embryos containing cells
with a lacZ cDNA inserted into the endogenous myf 5 locus Positively regulated transcription in our assay was de-
®ned as PCR products detected two or more cycles prior(Tajbakhsh and Buckingham, 1994). The earliest b-galactos-
idase staining occurred in E10 limbs, and no b-galactosidase to their detection in parallel samples from the nonskeletal
muscle control tissue (E11 heart). Therefore, because of theactivity was found in the lateral plate mesoderm or in the
earliest limbs, even though myogenic precursors are known differences in background transcription levels between myf
5, MRF 4, and MyoD, the number of target sequences re-to be present within the E9.25 limbs (Sassoon et al., 1989).
These data are consistent with the hypothesis that myf 5 quired for signi®cant transcript levels in this assay would
differ for each of the MDFs. For example, a signi®cant myfis not expressed in muscle precursors of the earliest mouse
limbs. However, this interpretation also depends on the as- 5 signal would require the presence of only a few target
sequences, while the detection of a signi®cant MyoD signalsumptions that insertion of the lacZ cDNA did not disturb
any temporal controls of myf 5 gene expression and that all would require a much greater number of target sequences.
These differences in background MDF mRNA levels mayof the early limbs contained high and uniform levels of
chimaerism (myf 5-lacZ and wild-type cells). be responsible for the greater sensitivity of myf 5 and MRF
4 RT-PCR assays.The MyoD PCR primers used in our study and the in
situ hybridization probes used by other investigators exhibit We examined MyoD, myf 5, and MRF 4 transcript levels
in other chick embryonic tissues by RT±PCR and foundroughly equivalent levels of sensitivity since our assays ®rst
detected MyoD mRNA at the same stage as observed by in unanticipated patterns of developmental and tissue expres-
sion. Signi®cant levels of MyoD transcripts were found onlysitu hybridization. In contrast, our myf 5 and MRF 4 PCR
primers appear to be much more sensitive than the probes in tissues containing skeletal muscle or skeletal muscle
precursors (Fig. 4 and Table 4), whereas signi®cant myf 5used for the in situ hybridization studies, i.e., myf 5 and
MRF 4 mRNAs were detected in tissues that were negative and MRF 4 levels were detected in these tissues as well as
in tissues not known to contain skeletal muscle precursors.for myf 5 and MRF 4 mRNA as assessed by in situ hybridiza-
tion (Ott et al., 1991; Bober et al., 1991; Hinterberger et al., For example, signi®cant levels of myf 5 and MRF 4 mRNA
were found in early neural tubes, an observation that corrob-1991).
Detection of mRNAs by in situ hybridization is highly orated those from myf 5-lacZ insertion studies that showed
myf 5 expression in the mouse embryo neural tube (Taj-dependent on the signal to noise ratio. In the case of radioac-
tive in situ hybridization probes, background noise could bakhsh et al., 1994).
Detection of myf 5 and MRF 4 transcripts in lateral platebe due to the combination of speci®c probe hybridization
to genomic DNA sequences, low levels of legitimate MDF is of interest, because this tissue contains precursors to
bone, cartilage, connective tissue, tendons, and smoothtranscripts from leaky gene transcription, nonspeci®c hy-
bridization, and random autoradiographic grain exposure. muscle cells that are found within the developing limb
(Christ et al., 1977, 1979). Transplants of quail lateral plateIn contrast, when intron-spanning PCR primers are used
and PCR product identity is veri®ed by diagnostic restric- mesoderm into chick hosts have yielded con¯icting results
as to whether lateral plate mesoderm can form muscletion enzyme digest, the only obvious contributor to back-
ground noise is the presence of mRNAs due to leaky gene (Christ et al., 1977, 1979; McLachlan and Hornbruch, 1979;
Mauger et al., 1980; Wachtler et al., 1982). While most stud-expression. ``Leaky'' transcription in tissues in which the
particular gene is not thought to function has been found ies support an exclusively somitic origin of skeletal muscle
cells, the role of myf 5 and MRF 4 in determining the myo-for a number of genes (Chelly et al., 1988; Montarras et
al., 1989). For example, b-globin mRNA was detected in genic potential of transplanted lateral plate mesoderm is
unclear.®broblast, hepatoma, and lymphoblast cell lines by RT±
PCR (Chelly et al., 1989). Detection of myf 5 and MRF 4 mRNA in the distal limb
does not correlate with the presence of muscle precursors,It was critical for our study to use a non-skeletal muscle
tissue such as E11 heart as the negative control for leaky since no myogenic cells were detected within this region
of stage 25 limbs by cell culture assays (Hauschka and Rutz,gene transcription in exactly parallel RT±PCR assays to
determine the earliest PCR cycle number at which back- 1982; Rutz et al., 1982). The apparent absence of skeletal
muscle precursors in lateral plate mesoderm and distal limbground transcripts were observed. For MyoD, extrapolation
of the data from Table 2 and Fig. 3B suggests that approxi- regions suggests that myf 5 and MRF 4 expression within
these cells does not cause an irreversible commitment tomately 30,000 transcripts of MyoD (1 transcript for every 3
cells) are found in 1 mg of total RNA from E11 heart. Similar myogenesis. If expression of myf 5 and MRF 4 in these
tissues does, indeed, provide the potential for initiatingcalculations for background levels of MRF 4 (Fig. 3A and
data not shown) suggest that there are approximately 1000 early phases of myogenesis, it is possible that further activa-
tion can occur only when the proper environmental condi-transcripts in 1 mg of E11 heart RNA (1 transcript for every
100 cells). In contrast, myf 5 PCR products can be detected tions are present.
The detection of myf 5 and MRF 4 transcripts in theonly occasionally in E11 heart after 40 cycles, even though
a single myf 5 target sequence can be detected in PCR sensi- nonmyogenic distal limb region as well as in the lateral
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plate has important interpretive consequences for our data. genic population increases, and the cells undergo at least
one phenotypic change that can be detected in cell culture.Namely, we cannot distinguish whether the myf 5 and MRF
4 transcripts detected in early limbs are due solely to non- During the stage 16±20 period myogenic cells are readily
observable via explant culture assays, but not via clonalmyogenic limb mesenchyme cells derived from the lateral
plate, or to both nonmyogenic and myogenic cell popula- assays (Hauschka and Rutz, 1982). This behavior changes
at stage 21 when muscle colony-forming cells ®rst appeartions. However, even if higher relative MDF transcript lev-
els could be localized to speci®c cells with myogenic poten- (Bonner and Hauschka, 1974). Two stages later, MyoD and
myogenin mRNAs appear, followed shortly by transcriptstial, as with in situ hybridization, it would still remain
to be determined whether the transcripts corresponded to associated with terminal muscle differentiation as exempli-
®ed by the appearance of troponin T mRNA in stage 26functional levels of MDF proteins, i.e., are the transcripts
translated, and are the MDF proteins in a functionally acti- limbs (Charles de la Brousse and Emerson, Jr., 1990). The
later appearance of myogenin transcripts is consistent withvated state with respect to regulating muscle gene expres-
sion? While it is tempting to use this PCR data to estimate data from myogenin null mutations in mice (Hasty et al.,
1993; Nabeshima et al., 1993) as well as with the patternabsolute concentrations of MDF transcripts per limb cell,
we believe that too many untested assumptions would be of myogenin expression in muscle culture (Edmondson and
Olson, 1989; Wright et al., 1989) and suggests the impor-required to derive such values. However, biologically sig-
ni®cant mRNA levels for certain liver enzymes have been tance of myogenin for muscle terminal differentiation.
MyoD may play a similar role to myogenin in terminalestimated to be as low as two molecules per cell (Galau et
al., 1977). differentiation, but it may also play a role in establishing
the myoblast subtypes that appear during subsequent em-The enigma of early and seemingly inappropriate MDF
gene expression is further illustrated by the detection of bryogenesis, e.g., the late muscle colony-forming cells
found in stage 25 hindlimbs (Rutz et al., 1982) or the colony-myf 5 mRNA in stage 3 chick embryos, while no myf 5
mRNA was present at stage 1 (Lin-Jones and Hauschka, forming cells that express different myosin heavy chain iso-
forms (Miller and Stockdale, 1986).manuscript in preparation). This observation suggests that
the myf 5 gene is activated during early gastrulation. How- This study has demonstrated that two muscle determina-
tion factor transcripts, myf 5 and MRF 4, are detected inever, its transcription must be subsequently repressed in
nonmyogenic tissues, since myf 5 transcripts were barely the earliest stages of limb development and in a variety of
myogenic as well as nonmyogenic embryonic tissues bydetectable in E11 heart and liver. An analogous pattern of
widely distributed, early MDF expression, followed by pro- RT±PCR. Myogenin and MyoD transcripts are found only
during later limb stages and appear to be associated withgressively restricted expression, is seen during Xenopus de-
velopment (Rupp and Weintraub, 1991). MyoD transcripts steps in myogenesis that slightly precede and/or coincide
with terminal differentiation. RT±PCR studies to examineare distributed throughout the embryo at the mid-blastula
transition; then as development proceeds, MyoD expression the developmental sequence of MDF gene expression during
somitogenesis are currently in progress and should deter-becomes restricted to cells of the muscle lineage.
Before the discovery of MDFs heterotopic limb trans- mine whether similar patterns of early and late MDF gene
expression also occur during myogenesis in the somite.plants, limb explant cultures, and limb clonal cell culture
assays were used to determine the presence of cells commit-
ted to the muscle lineage (see Table 5 footnotes for refer-
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